Fractyl Health, Inc. financial data

Symbol
GUTS on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
3 Van De Graaff Drive, Suite 200, Burlington, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
Fractyl Laboratories Inc. (to 3/19/2020)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 651 %
Quick Ratio 0.52 %
Debt-to-equity -288 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48.1M shares
Common Stock, Shares, Outstanding 48.1M shares
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 48M shares +2195%
Weighted Average Number of Shares Outstanding, Diluted 48M shares +2195%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 7K USD -72%
Research and Development Expense 19M USD +103%
Operating Income (Loss) -23.8M USD -71.5%
Nonoperating Income (Expense) 621K USD
Net Income (Loss) Attributable to Parent -23.2M USD -47.2%
Earnings Per Share, Basic -0.48 USD/shares +95%
Earnings Per Share, Diluted -0.48 USD/shares +95%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 84.7M USD
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD
Inventory, Net 73K USD
Assets, Current 87.7M USD
Property, Plant and Equipment, Net 3M USD
Operating Lease, Right-of-Use Asset 28.8M USD
Other Assets, Noncurrent 3.23M USD
Assets 127M USD
Accounts Payable, Current 1.77M USD
Liabilities, Current 15.7M USD
Operating Lease, Liability, Noncurrent 27.7M USD
Other Liabilities, Noncurrent 1.07M USD
Liabilities 76.6M USD
Retained Earnings (Accumulated Deficit) -390M USD
Stockholders' Equity Attributable to Parent 50.3M USD
Liabilities and Equity 127M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.7M USD -22.6%
Net Cash Provided by (Used in) Financing Activities 101M USD
Net Cash Provided by (Used in) Investing Activities -1.06M USD -5195%
Common Stock, Shares Authorized 300M shares
Common Stock, Shares, Issued 48.1M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 88.2M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 88.9M USD +81.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 621K USD
Depreciation 53K USD -33.8%
Payments to Acquire Property, Plant, and Equipment 1.06M USD +5195%
Lessee, Operating Lease, Liability, to be Paid 59.6M USD
Operating Lease, Liability, Current 4.92M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.98M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 5.82M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.82M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.74M USD
Additional Paid in Capital 441M USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 2.52M USD +131%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares